The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Real-world patterns of molecular testing in advanced melanoma (advMel): adherence to guidelines.

Anthony J.  Olszanski

Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Merck; Novartis; Pfizer

Research Funding - Adaptimmune (Inst); Alkermes (Inst); Astellas Pharma (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Checkmate Pharmaceuticals (Inst); EMD Serono (Inst); GlaxoSmithKline (Inst); GlycoNex (Inst); Immunocore (Inst); Incyte (Inst); Intensity Therapeutics (Inst); Kadmon (Inst); Kartos Therapeutics (Inst); Kura Oncology (Inst); Nektar (Inst); NGM Biopharmaceuticals (Inst); Oncoceutics (Inst); OncoSec (Inst); Seagen (Inst); Sound Biologics (Inst); Spring Bank (Inst); Takeda (Inst); Targovax (Inst)

Jeffrey M.  Farma

Other Relationship - Delcath Systems